DIVIDEND ANNOUNCEMENT: Lilly (Eli) & Co (NYSE:LLY) on 10/18/2021 declared a dividend of $0.8500 per share

Lilly (Eli) & Co (NYSE:LLY) on 10/18/2021 declared a dividend of $ 0.8500 per share payable on December 10, 2021 to shareholders of record as of November 15, 2021.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 1.4292920828% and has increased its dividends for 6 successive years.

Lilly (Eli) & Co's market cap is $ 227,551,488,280 and has a PE ratio of 35.66. The stock price closed yesterday at $ 237.88 and has a 52 week low/high of $ 129.21 and $ 275.87.

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.

For more information on Lilly (Eli) & Co click here.